AFC-HD AMS Life Science Co., Ltd. (TYO:2927)
Japan · Delayed Price · Currency is JPY 840.00
+10.00 (1.20%)
Jun 5, 2026, 3:30 PM JST
AFC-HD AMS Life Science Cash Flow Statement
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Net Income | 2,031 | 2,200 | 1,910 | 1,545 | 1,235 | 2,157 |
Depreciation & Amortization | 1,413 | 1,396 | 1,084 | 983 | 1,005 | 648 |
Loss (Gain) From Sale of Assets | 421 | 426 | -22 | 31 | 88 | 4 |
Loss (Gain) From Sale of Investments | -15 | -11 | -47 | -44 | -10 | 3 |
Other Operating Activities | -708 | -756 | -567 | -318 | -679 | -302 |
Change in Accounts Receivable | -423 | -147 | 156 | -206 | -332 | 294 |
Change in Inventory | -630 | -890 | -1,433 | -633 | 123 | -361 |
Change in Accounts Payable | 613 | -58 | 351 | -261 | 679 | -181 |
Change in Other Net Operating Assets | 347 | -374 | 108 | -232 | -617 | 320 |
Operating Cash Flow | 3,049 | 1,786 | 1,540 | 865 | 1,492 | 2,582 |
Operating Cash Flow Growth | 28.70% | 15.97% | 78.03% | -42.02% | -42.22% | 98.77% |
Capital Expenditures | -3,448 | -3,538 | -3,406 | -1,939 | -957 | -491 |
Sale of Property, Plant & Equipment | 50 | 44 | 658 | - | 3 | 3 |
Cash Acquisitions | - | - | 162 | -114 | 2 | 1 |
Investment in Securities | 60 | 151 | -188 | 254 | 388 | 147 |
Other Investing Activities | -236 | 17 | 13 | 64 | -513 | 66 |
Investing Cash Flow | -3,559 | -3,326 | -2,761 | -1,946 | -1,077 | -274 |
Short-Term Debt Issued | - | 1,065 | 1,003 | 1,093 | 2,853 | - |
Long-Term Debt Issued | - | 1,357 | 2,172 | 1,684 | 635 | 9,500 |
Total Debt Issued | 1,406 | 2,422 | 3,175 | 2,777 | 3,488 | 9,500 |
Short-Term Debt Repaid | - | - | - | - | - | -1,210 |
Long-Term Debt Repaid | - | -1,177 | -487 | -380 | -1,034 | -5,581 |
Total Debt Repaid | -1,225 | -1,177 | -487 | -380 | -1,034 | -6,791 |
Net Debt Issued (Repaid) | 181 | 1,245 | 2,688 | 2,397 | 2,454 | 2,709 |
Issuance of Common Stock | 258 | - | - | - | - | - |
Repurchase of Common Stock | - | -13 | - | -79 | -288 | -152 |
Common Dividends Paid | -476 | -434 | -418 | -385 | -421 | -312 |
Other Financing Activities | 62 | -132 | -38 | -52 | -586 | -60 |
Financing Cash Flow | 25 | 666 | 2,232 | 1,881 | 1,159 | 2,185 |
Foreign Exchange Rate Adjustments | 65 | 2 | -2 | 3 | 16 | 3 |
Miscellaneous Cash Flow Adjustments | 3 | 2 | -1 | 1 | - | - |
Net Cash Flow | -417 | -870 | 1,008 | 804 | 1,590 | 4,496 |
Free Cash Flow | -399 | -1,752 | -1,866 | -1,074 | 535 | 2,091 |
Free Cash Flow Growth | - | - | - | - | -74.41% | 127.78% |
Free Cash Flow Margin | -1.21% | -5.37% | -6.18% | -4.20% | 2.33% | 9.35% |
Free Cash Flow Per Share | -28.07 | -124.54 | -132.80 | -76.43 | 37.89 | 148.62 |
Cash Interest Paid | 236 | 193 | 97 | 58 | 58 | 31 |
Cash Income Tax Paid | 761 | 798 | 575 | 282 | 993 | 321 |
Levered Free Cash Flow | -1,007 | -2,330 | -1,029 | -1,497 | -66.13 | 3,658 |
Unlevered Free Cash Flow | -863.63 | -2,205 | -965.5 | -1,461 | -30.5 | 3,689 |
Change in Working Capital | -93 | -1,469 | -818 | -1,332 | -147 | 72 |